• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人组织激肽释放酶4:酶活性、抑制作用及细胞外基质蛋白的降解

Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins.

作者信息

Obiezu Chistina V, Michael Iacovos P, Levesque Michael A, Diamandis Eleftherios P

机构信息

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, and Department of Laboratory Medicine and Pathobiology, University of Toronto, 100 College Street, Toronto M5G 1L5, ON, Canada.

出版信息

Biol Chem. 2006 Jun;387(6):749-59. doi: 10.1515/BC.2006.094.

DOI:10.1515/BC.2006.094
PMID:16800736
Abstract

Human kallikrein 4 (hK4) is a member of the expanded family of human kallikreins, a group of 15 secreted proteases. While this protein has been associated with ovarian and prostate cancer prognosis, only limited functional information exists. Therefore, we have undertaken an investigation of its enzymatic properties regarding substrate preference, degradation of extracellular matrix proteins, and its inhibition by various inhibitors. We successfully expressed and purified active recombinant hK4 from supernatants of the Pichia pastoris expression system. This enzyme seems to cleave more efficiently after Arg compared to Lys at the P1 position and exhibits modest specificity for amino acids at positions P2 and P3. hK4 forms complexes with alpha1-antitrypsin, alpha2-antiplasmin and alpha2-macroglobulin. The protease mediates limited degradation of extracellular matrix proteins such as collagen I and IV, and more efficient degradation of the alpha-chain of fibrinogen. The cleavage of extracellular matrix proteins by hK4 suggests that this enzyme may play a role in tissue remodeling and cancer metastasis.

摘要

人激肽释放酶4(hK4)是扩展的人激肽释放酶家族成员,该家族由15种分泌型蛋白酶组成。虽然这种蛋白质与卵巢癌和前列腺癌的预后有关,但目前仅有有限的功能信息。因此,我们对其酶学特性进行了研究,包括底物偏好、细胞外基质蛋白的降解以及各种抑制剂对其的抑制作用。我们成功地从毕赤酵母表达系统的上清液中表达并纯化了活性重组hK4。与P1位置的赖氨酸相比,该酶似乎在精氨酸后切割效率更高,并且对P2和P3位置的氨基酸表现出适度的特异性。hK4与α1-抗胰蛋白酶、α2-抗纤溶酶和α2-巨球蛋白形成复合物。该蛋白酶介导细胞外基质蛋白如I型和IV型胶原的有限降解,以及纤维蛋白原α链的更有效降解。hK4对细胞外基质蛋白的切割表明该酶可能在组织重塑和癌症转移中发挥作用。

相似文献

1
Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins.人组织激肽释放酶4:酶活性、抑制作用及细胞外基质蛋白的降解
Biol Chem. 2006 Jun;387(6):749-59. doi: 10.1515/BC.2006.094.
2
Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins.人激肽释放酶8的生化特性及其在细胞外基质蛋白降解中的可能作用。
FEBS Lett. 2005 Dec 19;579(30):6879-84. doi: 10.1016/j.febslet.2005.11.039. Epub 2005 Dec 1.
3
Enzymatic profiling of human kallikrein 14 using phage-display substrate technology.使用噬菌体展示底物技术对人组织激肽释放酶14进行酶谱分析。
Biol Chem. 2005 Mar;386(3):291-8. doi: 10.1515/BC.2005.035.
4
Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site.人组织激肽释放酶4的晶体结构:特定锌结合位点对活性的调节
J Mol Biol. 2006 Oct 6;362(5):1094-107. doi: 10.1016/j.jmb.2006.08.003. Epub 2006 Aug 3.
5
Human kallikrein 13 involvement in extracellular matrix degradation.人激肽释放酶13参与细胞外基质降解。
Biochem Biophys Res Commun. 2004 Oct 22;323(3):1084-90. doi: 10.1016/j.bbrc.2004.08.206.
6
The extracellular matrix protein fibronectin is a substrate for kallikrein 7.细胞外基质蛋白纤连蛋白是组织激肽释放酶7的作用底物。
Biochem Biophys Res Commun. 2008 May 16;369(4):1169-73. doi: 10.1016/j.bbrc.2008.03.021. Epub 2008 Mar 14.
7
Expression and enzymatic characterization of recombinant human kallikrein 14.重组人激肽释放酶14的表达及酶学特性研究
Zoolog Sci. 2007 Aug;24(8):774-80. doi: 10.2108/zsj.24.774.
8
Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression.人组织激肽释放酶5(hK5)的生化与酶学特性,一种可能参与癌症进展的新型丝氨酸蛋白酶。
J Biol Chem. 2005 Apr 15;280(15):14628-35. doi: 10.1074/jbc.M408132200. Epub 2005 Feb 15.
9
Enzymatic properties of human kallikrein-related peptidase 12 (KLK12).人组织激肽释放酶相关肽酶12(KLK12)的酶学特性
Biol Chem. 2007 Apr;388(4):427-35. doi: 10.1515/BC.2007.049.
10
Characterization of mouse glandular kallikrein 24 expressed in testicular Leydig cells.在睾丸间质细胞中表达的小鼠腺体激肽释放酶24的特性分析。
Int J Biochem Cell Biol. 2005 Nov;37(11):2333-43. doi: 10.1016/j.biocel.2005.05.011.

引用本文的文献

1
Expression of Human Kallikreins 4, 8, 10, 11 and 13 in Pleomorphic Adenomas and Mucoepidermoid Carcinomas.人组织激肽释放酶4、8、10、11和13在多形性腺瘤和黏液表皮样癌中的表达
Iran J Pathol. 2016 Fall;11(4):334-344.
2
Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application.前列腺癌中的激肽释放酶相关肽酶:从分子功能到临床应用
EJIFCC. 2014 Oct 24;25(3):269-81. eCollection 2014 Oct.
3
Hydrogel Microwell Arrays Allow the Assessment of Protease-Associated Enhancement of Cancer Cell Aggregation and Survival.
水凝胶微孔阵列可用于评估蛋白酶相关的癌细胞聚集和存活增强情况。
Microarrays (Basel). 2013 Aug 22;2(3):208-27. doi: 10.3390/microarrays2030208.
4
Dental enamel development: proteinases and their enamel matrix substrates.牙釉质发育:蛋白酶及其牙釉质基质底物
ISRN Dent. 2013 Sep 16;2013:684607. doi: 10.1155/2013/684607.
5
Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.分泌蛋白组和降解组分析表明,激肽释放酶相关肽酶4、5、6和7在卵巢癌细胞中诱导转化生长因子β-1信号传导。
Mol Oncol. 2014 Feb;8(1):68-82. doi: 10.1016/j.molonc.2013.09.003. Epub 2013 Oct 1.
6
Metastasis of ovarian cancer is mediated by kallikrein related peptidases.卵巢癌的转移是由激肽释放酶相关肽酶介导的。
Clin Exp Metastasis. 2014 Jan;31(1):135-47. doi: 10.1007/s10585-013-9615-4. Epub 2013 Sep 17.
7
Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment.激肽释放酶相关肽酶 4 在腹水模拟微环境中诱导浆液性卵巢癌细胞产生紫杉醇耐药和形成多细胞球体。
PLoS One. 2013;8(2):e57056. doi: 10.1371/journal.pone.0057056. Epub 2013 Feb 25.
8
Mastering the canonical loop of serine protease inhibitors: enhancing potency by optimising the internal hydrogen bond network.掌握丝氨酸蛋白酶抑制剂的经典环:通过优化内部氢键网络提高效力。
PLoS One. 2011 Apr 27;6(4):e19302. doi: 10.1371/journal.pone.0019302.
9
Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema.除肺气肿以外疾病的 α1-抗胰蛋白酶增补疗法的疗效。
Orphanet J Rare Dis. 2011 Apr 12;6:14. doi: 10.1186/1750-1172-6-14.
10
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).激肽释放酶相关肽酶(KLKs)的天然和合成抑制剂。
Biochimie. 2010 Nov;92(11):1546-67. doi: 10.1016/j.biochi.2010.06.022. Epub 2010 Jul 6.